About Fiscus Ventures
Fiscus Ventures is a venture capital firm located in California, United States. As of Dec 2024, Fiscus Ventures has invested in 4 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Series D round of Cala Health A lot of funds co-invest with Fiscus Ventures, with names like Reimagined Ventures sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Portfolio Soonicorns
Fiscus Ventures' List of All Investments
Fiscus Ventures has a portfolio of 4 companies. Their most notable investments are in Exo and Mekonos.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, HealthTech and 2 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of all investments by Fiscus Ventures:
Vedanta Biosciences is developing therapeutics to treat autoimmune and inflammatory diseases. The company is developing therapeutics a proprietary consortium of regulatory T cell-inducing Clostridium bacteria in the human gut. The lead drugs developed are VE303 to treat infection caused by C. difficile (phase II), VE202 to treat inflammatory bowel diseases (phase I), VE800 for cancer immunotherapy (phase I), VE416 for food allergy (phase I), and VE707 for multi-drug resistant organisms (MDRO) (clinical trials).
Key facts about Vedanta Biosciences
- Founded Year: 2010
- Location: Cambridge (United States)
- Stage: Series E
- Total Funding till date: $350M
- Employee Count: 96 as on Mar 31, 2026
- Investors: Public Health Emergency, K2 HealthVentures and 38 Others
- Latest Funding Round: Series E, Feb 23, 2024, $*****
- Highlight: Editors' Pick
2. Cala Health
Developer of a wearable non-invasive neuromodulation device. The company has developed a neuromodulation device that aims to provide relief of hand tremors in adults with essential tremors. It combines a watch-like device with an implantable sensor that externally stimulates peripheral nerves to reduce the same. The company has also developed a portable medical device with sensors to monitor the physical movement of a patient wearing or carrying the device.
Key facts about Cala Health
- Founded Year: 2013
- Location: Stanford (United States)
- Stage: Series D
- Total Funding till date: $257M
- Employee Count: 108 as on Mar 31, 2026
- Investors: AME Cloud Ventures, Innovatus Capital Partners and 28 Others
- Latest Funding Round: Series D, Oct 20, 2025, $*****
- Highlight: Editors' Pick
3. Exo
Developer of point of care ultrasound ecosystem with AI-powered diagnostic and workflow tools. It provides handheld ultrasound devices that replaces carts and probes designed for medical imaging at the point of care. It offers technology that automates image capture and quantification. The ecosystem includes workflow software designed around the user.
Key facts about Exo
- Founded Year: 2015
- Location: Redwood City (United States)
- Stage: Series C
- Total Funding till date: $428M
- Employee Count: 192 as on Mar 31, 2026
- Investors: RA Capital Management, BlackRock and 22 Others
- Latest Funding Round: Series C, May 28, 2025, $*****
- Highlight: Editors' Pick
_1532328743043.png?format=webp&height=120&width=120){kind=logo}
4. Mekonos
Mekonos has is a nanorobotics developing company. The company has developed silicon-based nanorobotic chips for cell engineering. The nanorobots deliver biomolecules to the cells for genetic engineering. The cell therapy procedure can be used for the treatment of cancer.
Key facts about Mekonos
- Founded Year: 2016
- Location: Palo Alto (United States)
- Stage: Series A
- Total Funding till date: $29.6M
- Employee Count: 27 as on Jul 01, 2024
- Investors: Sands Capital, Magnetar and 15 Others
- Latest Funding Round: Series A, Nov 09, 2021, $*****
- Highlight: Editors' Pick
Fiscus Ventures' Year-on-Year Investment Trends
Fiscus Ventures has invested in 4 companies over the last 6 years, with an average of 1 new investment annually in the last 5 years. Its most recent first time investment was in Cala Health.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2022 | 0 | 0 | 0 |
2021 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
Fiscus Ventures' Investments by Stage
Fiscus Ventures has made 1 investment in Series A stage with an average round size of $25M, 1 investment in Series B stage with an average round size of $40M, 1 investment in Series D stage with an average round size of $50M and 1 investment in Series E stage with an average round size of $118M.Stage of entry | No. of Investments |
|---|---|
Series A | 1 |
Series B | 1 |
Series D | 1 |
Series E | 1 |
Note: We have considered here, only first round of investments
Fiscus Ventures' Investments by Sector
Fiscus Ventures has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, High Tech, Artificial Intelligence - Industry Applications and Enterprise Applications. Notably, it has invested in 4 Tech companies, 3 Enterprise (B2B) companies, 1 AI-Native company and at least 1 company focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
HealthTech | 2 |
High Tech | 2 |
Artificial Intelligence - Industry Applications | 1 |
Enterprise Applications | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Fiscus Ventures' Investments by Geography
Fiscus Ventures has made most investments in United States (4).Fiscus Ventures' recent investments
Fiscus Ventures has not made any investment in 2026 so far.Here are the most recent investments by Fiscus Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 09, 2024 | United States | Series D | 3655 | [+11] | |
Mar 01, 2023 | United States | Series E | 2442 | [+15] | |
Nov 09, 2021 | United States | Series A | 7936 | [+8] | |
Aug 20, 2020 | United States | Series B | 8942 | [+10] |
Co-investors of Fiscus Ventures
Over the past 6 years, 87 investors have co-invested in Fiscus Ventures's portfolio companies. This includes only funds.
- Invested before Fiscus Ventures: Magnetar, Novartis and 55 others have invested in rounds before Fiscus Ventures. There are 2 companies where Magnetar has invested before Fiscus Ventures and 2 companies where Novartis has invested before Fiscus Ventures.
- Top Co-investors of Fiscus Ventures: 23 investors entered a company along with Fiscus Ventures. These include investors like Reimagined Ventures (4 companies).
- Invested after Fiscus Ventures: A total of 7 investors have invested in Fiscus Ventures's portfolio after their investments. Top Investors include Colorcon (1 company), Niterra (1 company) and BlackRock (1 company).
